Comparing Glucagon‐like peptide‐1 receptor agonists versus metformin in drug‐naive patients: A nationwide cohort study
GLP-1 RA was associated with a reduced risk of additional glucose-lowering medication, achieving better glycated hemoglobin control overall. However, among patients with prediabetes, metformin was associated with better adherence.
Authors
- Henrik Enghusen Poulsen (ORCID: https://orcid.org/0000-0003-4242-9924)
- Kathrine Kold Sørensen (ORCID: https://orcid.org/0000-0002-9402-1317)
- Bochra Zareini (ORCID: https://orcid.org/0000-0002-3891-5957)
- Ulrik Pedersen‐Bjergaard (ORCID: https://orcid.org/0000-0003-0588-4880)
- Lars Køber (ORCID: https://orcid.org/0000-0002-6635-1466)
- Mikkel Porsborg Andersen (ORCID: https://orcid.org/0000-0001-6162-5205)
- Emil Loldrup Fosbøl (ORCID: https://orcid.org/0000-0002-2048-4167)
- Christian Tobias Torp-Pedersen (ORCID: https://orcid.org/0000-0003-2892-6131)
- Thomas Alexander Gerds (ORCID: https://orcid.org/0000-0002-5955-816X)
- Amalie Lykkemark Møller
Institutions
- University of Copenhagen (DK)
- Frederiksberg Hospital (DK)
- Zealand University Hospital (DK)
- Nordsjællands Hospital (DK)
- Danish Cancer Society (DK)
Publication Details
- Journal
- Journal of Diabetes
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1111/1753-0407.70000
- Citations
- 8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.86